Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients

  • H. J. Kolb
  • , J. Mittermüller
  • , Ch Clemm
  • , E. Holler
  • , G. Ledderose
  • , G. Brehm
  • , M. Heim
  • , W. Wilmanns

Research output: Contribution to journalArticlepeer-review

1435 Scopus citations

Abstract

Three patients with hematologic relapse after bone marrow transplantation for chronic myelogenous leukemia were treated with interferon α and transfusion of viable donor buffy coat. All had complete hematologic and cytogenetic remission, which persisted 32 to 91 weeks after treatment. In two patients graft-versus-host disease developed and was treated by immunosuppression. These results are an example of adoptive immunotherapy without cytoreductive chemotherapy or radiotherapy in human chimeras.

Original languageEnglish
Pages (from-to)2462-2465
Number of pages4
JournalBlood
Volume76
Issue number12
StatePublished - 15 Dec 1990
Externally publishedYes

Fingerprint

Dive into the research topics of 'Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients'. Together they form a unique fingerprint.

Cite this